Topics

Companies Related to "Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication" [Most Relevant Company Matches] RSS

03:20 EST 25th January 2020 | BioPortfolio

Here are the most relevant search results for "Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication" found in our extensive corporate database of over 50,000 company records.

Showing "Intermittent Negative Pressure Impact Peripheral Artery Disease Intermittent" Companies 1–25 of 3,600+

Extremely Relevant

Pathway Medical Technologies Inc.

Pathway Medical Technologies, Inc. (Pathway), located in Redmond, Washington was founded in 1998 to design, develop and manufacture innovative medical devices intended for the treatment of arterial disease. The company’s initial focus is on peripheral artery disease (PAD).According to the American Heart Association, peripheral artery disease affects 8 – 12 million in the U.S. PAD prevalence in...


Intact Vascular

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Intact Vascular, Inc.

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment paradigm for treating peripheral ...


Intact Vascular, LLC

Intact Vascular is a privately held medical device company that develops minimally invasive peripheral vascular products. The Tack-It Endovascular Stapler™ is designed to optimize peripheral balloon angioplasty results in the treatment of peripheral artery disease. This technology will offer physicians a new treatment option for treating peripheral ar...

Healthy Life Screening

Located in Akron, Ohio, Healthy Life Screening was started in 2006 offering a range of preventive health screens on asymptomatic individuals for the presence of cardiovascular disease. The screening consists of five tests: left ventricle dysfunction, peripheral artery disease, abdominal aortic, carotid artery screening (including carotid intima-media thick...

Relevant

t2cure GmbH

t2cure is dedicated to the development of novel progenitor cell-based regenerative therapeutics to provide new treatment options to patients suffering from cardiac or peripheral vascular diseases like myocardial infarction or peripheral artery occlusive disease.

PQ Bypass

PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions.

PQ Bypass, Inc.

PQ Bypass, Inc. is a Silicon Valley-based medical device company working to transform the treatment of long-segment peripheral artery disease with minimally-invasive endovascular solutions.

Foxhollow Technologies

An estimated 12 million people in the U.S. alone have peripheral arterial disease (PAD). At least 40% of them also suffer from coronary artery disease (CAD). FoxHollow recently launched the SilverHawk® Plaque Excision System, a device that removes the plaque that commonly blocks arteries and interrupts blood flow. Unlike stenting and other methods of opening the artery, the SilverHawk removes the...

Amsterdam Molecular Therapeutics B.V

AMT, founded in 1998 and based in Amsterdam, is a leader in the development of human gene based therapies. Using adeno-associated viral (AAV) vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate what is probably the first stable and scalable AAV production platform. This safe and efficacious proprietary platform offers a unique manuf...

Fist Assist Devices, LLC

Fist Assist Devices, LLC is a privately held company located in Silicon Valley, Calif. that has developed the patent-protected Fist Assist technology over the past 30 years. Fist Assist Devices, LLC is focused on developing and marketing an intermittent, external wearable pneumatic compression to increase arm vein enhancement and AV fistula dilation. The d...

Pervasis Therapeutics, Inc.

More than eight million Americans over the age of 50 have peripheral arterial disease (PAD), a serious condition in which plaque builds up in arteries, restricting blood flow. PAD has significant health implications, including high blood pressure, reduced ability to walk, leg pain, and increased risk for heart attack and stroke.

Sleep HealthCenters®, Inc.

It is estimated that at least 40 million Americans suffer from a chronic sleep disorder or intermittent sleep-related problem. Sleep deprivation is an unhealthy, dangerous and costly problem.Sleep HealthCenters® is a recognized network of specialized sleep medicine centers, staffed by experts in the field of sleep medicine. Sleep HealthCenters® utilizes the most current technologies available to...

deCODE genetics

deCODE is a biopharmaceutical company applying its discoveries in human genetics to the development of drugs for common diseases. deCODE is a global leader in gene discovery - our population approach and resources have enabled us to isolate key genes contributing to major public health challenges from cardiovascular disease to cancer, genes that are providing us with drug targets rooted in the bas...

Pharmacology Research Institute

PRI is an internationally recognized research organization with expertise in pharmacological and multidisciplinary research. Our staff is experienced in the fields of psychiatry, cardiology, rheumatology, family practice, neurology, ophthalmology, gerontology, pharmacoeconomics and quality of life measures.Diagnostic categories treated have included adult attention deficit hyperactivity disorders ...

Transvivo Incorporated

Transvivo's SCIPTM System was acclaimed as a "revolutionary" new development in therapeutic apheresis during the 2004 Joint Meeting of the World and American Societies for Apheresis. Clinical trials have begun with the plasmapheresis catheter which continuously filters blood inside the body for a hemodynamically-stable therapeutic alternative to intermittent blood purification therapies such as pl...

Micro Medical Solutions

Micro Medical Solutions is on a mission to provide solutions to some of the most pressing unmet needs in microvascular intervention by helping to significantly reduce the rate of amputations, improve clinical outcomes and patient quality of life, and minimize the financial and human costs associated with the treatment of peripheral artery disease and criti...

uniQure

uniQure is a world leader in the development of human gene based therapies. uniQure product pipeline of gene therapy products in development comprise hemophilia B, acute intermittent porphyria, Parkinson’s disease and SanfilippoB. Using adeno-associated viral (AAV) derived vectors as the delivery vehicle of choice for therapeutic genes, the company has been able to design and validate prob...

Avinger Inc.

Founded in 2007 by renowned cardiologist and medical device entrepreneur Dr. John B. Simpson, Avinger develops next-generation catheter-based technologies for the treatment of peripheral artery disease (PAD). Leveraging core competencies in medical device catheter engineering and intravascular Optical Coherence Tomography (OCT), Avinger globally marketsÂ...

Independence Plus, Inc.

For more than 32 years, Independence Plus, Inc. (IPI) has been a leading provider of complex care at-home with an integrated approach conducted by a multidisciplinary team. We specialize in treating adult and pediatric patients with complex medical and respiratory needs, offering the highest quality one-on-one care with 24/7 on-call clinical management support, skilled intermittent visits and hig...

PlaqueTec Ltd.

PlaqueTec offers a first-of-its-kind catheter technology for cardiologists to routinely assess inflammation in the coronary artery, and better understand residual inflammatory risk. It has been proven to detect inflammatory molecules across the site of coronary artery disease (CAD), and can discriminate between patients with greater and lesser levels of co...

Society of Interventional Radiology

Interventional radiologists are physicians who specialize in minimally invasive, targeted treatments. They offer the most in-depth knowledge of the least invasive treatments available coupled with diagnostic and clinical experience across all specialties. They use X-ray, MRI and other imaging to advance a catheter in the body, such as in an artery, to treat at the source of the disease internally....

Bacchus Vascular, Inc.

Bacchus Vascular, Inc. is a privately held medical device company dedicated to the treatment of peripheral vascular disease. Dr. Thomas Fogarty, a noted inventor and cardiovascular surgeon, founded the company with the vision of transforming blood clot removal from peripheral blood vessels into a fast, simple, minimally-invasive catheter-based procedure. Thousands of patients suffering from D...

Biomedix, Inc

BioMedix is the fastest growing provider of equipment and services in the market for noninvasive detection of peripheral vascular disease (PVD). Unique technology also links PCP's and Vascular Specialists in the early detection of peripheral arterial disease (PAD) through simple web-enabled vascular testing devices, software and services. Innovative Vascular Lab and Surgery suite management softwa...

Minnow Medical, Inc.

Minnow Medical is an innovative cardiovascular medical device company applying its extensive experience in cardiovascular biology, radiofrequency energy and tissue biology to the treatment of peripheral artery disease. The Company’s recently developed Z Cath™ System combines a balloon angioplasty catheter with non-ablative radio frequency energy ...


More From BioPortfolio on "Intermittent Negative Pressure; Impact on Peripheral Artery Disease and Intermittent Claudication"

Quick Search

Corporate Database Quicklinks